A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency

Clinical trial NCT07347249 · RECRUITING

Trial details

NCT number: NCT07347249
Sponsor: Hemab ApS
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Congenital Factor VII Deficiency

Start date: 2026-03-11
Primary completion: 2027-11-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.